Table 1.

Study participants’ information.

Disease type	Ulcerative colitis [n = 41]
Medication group	No medication [n = 2]	5-ASA [n = 15]	Imuran [n = 4]	Biologics [n = 16]	Topical [n = 4]
Gestation [weeks]	38.93	39.17	35.68	39.55	39.89
% C-section	100 [2]	27 [4]	50 [2]	31 [5]	75 [3]
% Anti-TNF	0	0	0	75 [12]	0
% Anti-integrin	0	0	0	25 [4]	0
% Monotherapy	0	0	0	63 [10]	0
Disease type	Crohn’s disease [n = 31]
Medication group	No medication [n = 3]	5-ASA [n = 3]	Imuran [n = 5]	Biologics [n = 18]	Topical [n = 2]
Gestation [weeks]	37.67	39.095	38.14	38.85	33
% C-section	33 [1]	33 [1]	40 [2]	100 [18]	100 [2]
% Anti-TNF	0	0	0	100 [18]	0
% Monotherapy	0	0	0	33 [6]	0

Healthy group had gestation age ≥37.9 weeks, 30% C-section, and were without any treatments.

5-ASA, 5-aminosalicylic aid; C-section, caesarean section.